IDT Biologika GmbH

IDT Biologika GmbH is a leading global Contract Development and Manufacturing Organization (CDMO) with over 100 years of expertise in the development and manufacture of vaccines, gene & immune therapeutics, and aseptic fill-finish of sterile injectables. Headquartered in Dessau-Rosslau, 49, the company provides end-to-end solutions to pharmaceutical and biotech companies worldwide, combining scientific excellence with regulatory compliance and innovative manufacturing capabilities. The company specializes in vaccine development and manufacturing, including live and inactivated vaccines for both human and animal health. In addition, IDT Biologika delivers advanced solutions in gene and immune therapeutics, offering viral vectors for gene therapy and immunotherapy applications. Their sterile injectables services include aseptic fill-finish, lyophilization, and secondary packaging, ensuring the highest quality and safety standards for biologics. With state-of-the-art facilities in 49, IDT Biologika serves clients worldwide, adhering to international regulatory standards and delivering reliable, high-quality pharmaceutical products. Guided by the vision to be a trusted partner in shaping a healthier world, the company is dedicated to advancing global health through innovative therapies. Committed to sustainability and ethical practices, IDT Biologika integrates environmental responsibility, social impact, and governance across all operations, ensuring that their growth positively contributes to healthcare and the communities they serve.